<DOC>
	<DOCNO>NCT02546323</DOCNO>
	<brief_summary>The purpose study evaluate effect rosuvastatin 20 mg compare placebo treat Chinese patient subclinical atherosclerosis .</brief_summary>
	<brief_title>A phase3 Study Measuring Effect Rosuvastatin 20 mg Carotid Intima-Media Thickness Chinese Subjects With Subclinical Atherosclerosis</brief_title>
	<detailed_description>This study randomize , double-blind , placebo-controlled , multicenter parallel group study assess effect rosuvastatin 20 mg treatment 104 week change intimamedia thickness ( IMT ) common carotid artery ( CCA ) , carotid bulb , internal carotid artery ( ICA ) adult Chinese subject subclinical atherosclerosis .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Provision inform consent prior studyspecific procedure Male age ≥45 &lt; 70 year female age ≥55 &lt; 70 year Subjects hypertension ( define blood pressure ≥140/90 mmHg antihypertensive treatment ) age CVD risk factor subject without hypertension 3 risk factor ( include age ) must `` Fasting LDL C ≥120 mg/dL ( 3.1 mmol/L ) &lt; 160 mg/dL ( 4.1mmol/L ) '' ; Subjects without hypertension few 3 risk factor ( include age ) must `` Fasting LDLC ≥120 mg/dL ( 3.1 mmol/L ) &lt; 190 mg/dL ( 4.9 mmol/L ) '' Triglycerides &lt; 500 mg/dL ( 5.65 mmol/L ) Visit 1 HDLC level ≤60 mg/dL ( 1.6 mmol/L ) Visit 1 Maximum IMT ≥1.2 mm &lt; 3.5 mm location carotid ultrasound scan conduct Visit 2 Visit 3 Willing follow study procedure include study visit , fast blood draw , compliance study treatment regimen Use pharmacologic lipidlowering medication ( eg , statin , fibrate derivative , bile acid binding resin , niacin , analogue dos &gt; 400 mg prescribe Chinese traditional drug ) , include cholesterolabsorption inhibitor ( CAIs ) , CAI/statin combination , within 12 month prior Visit 1 Current recent ( within 2 week Visit 1 ) use supplement know alter lipid metabolism ( eg , soluble fiber [ include &gt; 2 teaspoon Metamucil® psylliumcontaining supplement per day ] dietary fiber supplement , marine oil , sterol/stanol product , supplement determine discretion investigator ) History hypersensitivity reaction HMGCoA reductase inhibitor Pregnant woman , woman breastfeed , woman childbearing potential use chemical mechanical contraception positive serum pregnancy test Clinical evidence coronary artery disease ( CAD ) atherosclerotic disease angina , MI , transient ischemic attack , symptomatic CAD , cerebrovascular accident , percutaneous coronary intervention , coronary artery bypass graft , peripheral arterial disease , abdominal aortic aneurysm History cancer ( basal cell carcinoma ) past 2 year Uncontrolled hypertension define either mean rest diastolic blood pressure ≥110 mmHg rest systolic blood pressure ≥180 mmHg record time screen period History diabetes mellitus current diabetes mellitus Uncontrolled hypothyroidism define thyroid stimulate hormone ( TSH ) &gt; 1.5 time upper limit normal ( ULN ) Visit 1 subject whose thyroid replacement therapy initiate within last 3 month History heterozygous homozygous familial hypercholesterolemia know hyperlipoproteinemia Types I , III , IV , V ( familial dysbetalipoproteinemia ) Use disallow concomitant medication within 12 month prior Visit 1 History alcohol and/or drug abuse within past 5 year Active liver disease hepatic dysfunction define elevation ≥1.5 x ULN Visit 1 follow liver function test : ALT , AST bilirubin Serum creatine kinase ( CK ) &gt; 3 x ULN Visit 1 Serum creatinine &gt; 2.0 mg/dL ( 177 mmol/L ) record screening period Participation another investigational drug study , ingested investigational drug ≤4 week enrollment screen period Previous randomization present study History significant medical psychological condition , opinion investigator , would compromise subject 's safety successful participation study Involvement planning and/or conduct study ( applies AstraZeneca staff and/or staff study site )</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Rosuvastatin 20 mg treatment , Carotid Intima-Media Thickness , Chinese subject , Subclinical atherosclerosis</keyword>
</DOC>